CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of 15 million
Provides immediate new financing to support the Company’s next strategic milestones Strengthens…
Canara HSBC Life Insurance Closes FY26 with 19% WPI Growth; Gross Premium Crosses 10,000 Crore
Delivers one of the highest WPI growth amongst top 10 life insurers…
Dubai announces largest demand-led expansion of a financial centre in the Middle East, Africa and South Asia – with a total gross floor area of 17.7mn sq.ft.
DUBAI, UAE, Jan. 27, 2026 /PRNewswire/ -- His Highness Sheikh Mohammed bin…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 20, 2026 17:31 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo.,…
DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross…
Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin
October 31, 2025 17:00 ET | Source: Lucas GC Limited NEW YORK,…
Evernorth to Go Public With Over $1 Billion in Gross Proceeds
Transaction will create the largest public XRP treasury company SAN FRANCISCO, Oct.…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds
Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:…
